Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dionísio Henrique Amaral da Silva, Humberto de Moura Barbosa, Raphaelle Lima de Almeida Beltrão, Clarissa de França Oliveira Silva, Celuane Alves Moura, Rosane Nora Castro, Jackson Roberto Guedes da Silva Almeida, Dayane Aparecida Gomes & Eduardo Carvalho Lira. (2021) Hexane fraction from Brazilian Morus nigra leaves improved oral carbohydrate tolerance and inhibits α-amylase and α-glucosidase activities in diabetic mice. Natural Product Research 35:22, pages 4785-4788.
Read now
Read now
Mark Peyrot, Timothy S. Bailey, Belinda P. Childs & Gérard Reach. (2018) Strategies for implementing effective mealtime insulin therapy in type 2 diabetes. Current Medical Research and Opinion 34:6, pages 1153-1162.
Read now
Read now
Stanley S. Schwartz & Intekhab Ahmed. (2016) Sodium–glucose cotransporter 2 inhibitors: an evidence-based practice approach to their use in the natural history of type 2 diabetes. Current Medical Research and Opinion 32:5, pages 907-919.
Read now
Read now
Qiang Du, Yan-Jun Wang, Sheng Yang & Ping Han. (2015) Clinical utility and patient considerations in the use of the sitagliptin–metformin combination in Chinese patients. Patient Preference and Adherence 9, pages 281-287.
Read now
Read now
Articles from other publishers (42)
Suman Prakash Pradhan, Ashok GC, Prayon Joshi & Bishnu Prasad Pandey. (2023) Elemental analysis and enzymes inhibitory potential of the soybean and soy products available in Nepal. Journal of Agriculture and Food Research 12, pages 100574.
Crossref
Crossref
A. Isman, A. Nyquist, M. Moel, X. Zhang & S. Zalzala. (2023) The efficacy and tolerability of intermittent prandial acarbose to reduce glucose spikes in healthy individuals. Translational Medicine of Aging 7, pages 12-19.
Crossref
Crossref
Haimanot Mitiku, Tae Yang Kim, Hanna Kang, Emmanouil Apostolidis, Jung-Yun Lee & Young-In Kwon. (2022) Selected coffee (Coffea arabica L.) extracts inhibit intestinal α-glucosidases activities in-vitro and postprandial hyperglycemia in SD Rats. BMC Complementary Medicine and Therapies 22:1.
Crossref
Crossref
Yuting Sun & Chaoyun Liang. (2022) Urban–Rural Comparison of the Association between Unsupportive Relationships, Perceived Stress, Authentic Self-Presentation, and Loneliness among Young Adults in Taiwan. International Journal of Environmental Research and Public Health 19:14, pages 8808.
Crossref
Crossref
Thilina Gunathilaka, Lakshika Rangee Keertihirathna & Dinithi Peiris. 2022. Natural Medicinal Plants. Natural Medicinal Plants.
AshokK Das, SubhashK Wangnoo, Rajeev Chawla, Altamash Shaikh, Ganapathi Bantwal, Pramila Kalra, Shalini Jaggi, MaheshV Abhyankar, Ashish Prasad & Prashant Sarda. (2022) Expert consensus on triple combination of glimepiride, metformin, and voglibose usage in patients with type 2 diabetes mellitus in Indian settings. Journal of Diabetology 13:2, pages 145.
Crossref
Crossref
Ali Ahmadi, Yunes Panahi, Thomas P. Johnston & Amirhossein Sahebkar. (2021) Antidiabetic drugs and oxidized low-density lipoprotein: A review of anti-atherosclerotic mechanisms. Pharmacological Research 172, pages 105819.
Crossref
Crossref
Hideo Satsu, Ryosuke Shibata, Hiroto Suzuki, Shimon Kimura & Makoto Shimizu. (2021) Inhibitory Effect of Tangeretin and Cardamonin on Human Intestinal SGLT1 Activity In Vitro and Blood Glucose Levels in Mice In Vivo. Nutrients 13:10, pages 3382.
Crossref
Crossref
Makoto Ohara, Hiroe Nagaike, Tomoki Fujikawa, Yo Kohata, Maiho Ogawa, Takemasa Omachi, Risa Sasajima, Hirotoshi Chiba, Toshimasa Ara, Ayuka Sugawara, Munenori Hiromura, Michishige Terasaki, Yusaku Mori, Tomoyasu Fukui, Tsutomu Hirano, Hiroki Yokoyama & Sho-ichi Yamagishi. (2021) Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study. Diabetes Research and Clinical Practice 179, pages 108999.
Crossref
Crossref
Rosario Pivonello, Irina Bancos, Richard A. Feelders, Atil Y. Kargi, Janice M. Kerr, Murray B. Gordon, Cary N. Mariash, Massimo Terzolo, Noel Ellison & Andreas G. Moraitis. (2021) Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. Frontiers in Endocrinology 12.
Crossref
Crossref
Vincent Do, Danielle Haakinson, Renata Belfort-DeAguiar & Elizabeth Cohen. (2021) Implementing a pharmacist-led transition of care model for posttransplant hyperglycemia. American Journal of Health-System Pharmacy 78:13, pages 1207-1215.
Crossref
Crossref
Nadine A. Pringle, Maryna van de Venter & Trevor C. Koekemoer. (2021)
Comprehensive
in vitro
antidiabetic screening of
Aspalathus linearis
using a target-directed screening platform and cellomics
. Food & Function 12:3, pages 1020-1038.
Crossref
Crossref
Zuo-Di Fu, Xiao-Ling Cai, Wen-Jia Yang, Ming-Ming Zhao, Ran Li & Yu-Feng Li. (2021) Novel glucose-lowering drugs for non-alcoholic fatty liver disease. World Journal of Diabetes 12:1, pages 84-97.
Crossref
Crossref
Sherif S. FaragMohammad Abu ZaidJennifer E. SchwartzTeresa C. ThakrarAnn J. BlakleyRafat AbonourMichael J. RobertsonHal E. BroxmeyerShuhong Zhang. (2021) Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease. New England Journal of Medicine 384:1, pages 11-19.
Crossref
Crossref
Pavithra Mettupalayam Kaliyannan Sundaramoor & Kannan Kilavan Packiam. (2020) In vitro enzyme inhibitory and cytotoxic studies with Evolvulus alsinoides (Linn.) Linn. Leaf extract: a plant from Ayurveda recognized as Dasapushpam for the management of Alzheimer’s disease and diabetes mellitus. BMC Complementary Medicine and Therapies 20:1.
Crossref
Crossref
Ahmed Nokhala, Qamar Uddin Ahmed, Mohammed S. M. Saleh, Tanzina Sharmin Nipun, Al’aina Yuhainis Firus Khan & Mohammad Jamshed Siddiqui. (2019) Characterization of α-glucosidase inhibitory activity of Tetracera scandens leaves by Fourier transform infrared spectroscopy-based metabolomics. Advances in Traditional Medicine 20:2, pages 169-180.
Crossref
Crossref
Telesphore Benoit Nguelefack, Christian Kuete Fofie, Elvine Pami Nguelefack-Mbuyo & Adeline Kaptue Wuyt. (2020)
Multimodal
α
-Glucosidase and
α
-Amylase Inhibition and Antioxidant Effect of the Aqueous and Methanol Extracts from the Trunk Bark of
Ceiba pentandra
. BioMed Research International 2020, pages 1-13.
Crossref
Crossref
Jing Liu, Xia Jiang, Binhua Xu, Guoping Wang, Nan Cui, Xia Zhang, Jingcheng Liu, Yiming Mu & Lixin Guo. (2020) Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V). Advances in Therapy 37:4, pages 1675-1687.
Crossref
Crossref
Young Min Cho, Chaicharn Deerochanawong, Samroeng Seekaew, Swangjit Suraamornkul, Sunun Benjachareonwong, Sarinya Sattanon, Parinya Chamnan, Thanitha Sirirak, Natapong Kosachunhanun, Thongchai Pratipanawatr, Sompongse Suwanwalaikorn, Woo Je Lee, Sungrae Kim, Seonghui Choi, Eun Seok Kang, Taekeun Oh, Sam Kwon & Moon‐Kyu Lee. (2019) Efficacy and safety of gemigliptin as add‐on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study). Diabetes, Obesity and Metabolism 22:1, pages 123-127.
Crossref
Crossref
Eman A. Elbassuoni & Rasha F. Ahmed. (2019) Mechanism of the neuroprotective effect of GLP-1 in a rat model of Parkinson's with pre-existing diabetes. Neurochemistry International 131, pages 104583.
Crossref
Crossref
Rimei Nishimura, Takeshi Osonoi, Yasuhiro Koike, Kouji Miyata & Yukio Shimasaki. (2019) A Randomized Pilot Study of the Effect of Trelagliptin and Alogliptin on Glycemic Variability in Patients with Type 2 Diabetes. Advances in Therapy 36:11, pages 3096-3109.
Crossref
Crossref
Lau Zhi Ch'ng, Mohd Yusof Barakatun-Nisak, Wan Zul Haikal Wan Zukiman, Faridah Abas & Norasyikin A. Wahab. (2019) Nutritional strategies in managing postmeal glucose for type 2 diabetes: A narrative review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:4, pages 2339-2345.
Crossref
Crossref
Lorenzo Nesti, Alessandro Mengozzi & Domenico Tricò. (2019) Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications. Frontiers in Endocrinology 10.
Crossref
Crossref
Tricia Santos Cavaiola, Yan Kiriakov & Timothy Reid. (2019) Primary Care Management of Patients With Type 2 Diabetes: Overcoming Inertia and Advancing Therapy With the Use of Injectables. Clinical Therapeutics 41:2, pages 352-367.
Crossref
Crossref
Guillermo E. Umpierrez & Boris P. Kovatchev. (2018) Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes. The American Journal of the Medical Sciences 356:6, pages 518-527.
Crossref
Crossref
Flávia G. Cândido, Fernanda C.E. de Oliveira, Mário Flávio C. Lima, Carina A. Pinto, Letícia L. da Silva, Hércia S.D. Martino, Marcelo H. dos Santos & Rita de Cássia G. Alfenas. (2018) Addition of pooled pumpkin seed to mixed meals reduced postprandial glycemia: a randomized placebo-controlled clinical trial. Nutrition Research 56, pages 90-97.
Crossref
Crossref
Wenjia Yang, Xiaoling Cai, Xueying Gao, Yifei Chen, Ling Chen & Linong Ji. (2018) Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis. Journal of Diabetes Investigation 9:4, pages 813-821.
Crossref
Crossref
Hua Shu, Juming Lu, Puhong Zhang, Dongshan Zhu, Xian Li, Jiachao Ji, Fang Zhao & Linong Ji. (2018)
Clinical characteristics of type 2 diabetes patients with discordance between HbA
1c
and fasting plasma glucose in the real world: An analysis of the ORBIT study
. Diabetes/Metabolism Research and Reviews 34:4, pages e2977.
Crossref
Crossref
Júlia Novaes, Ryan Lillico, Casey Sayre, Kalyanam Nagabushanam, Muhammed Majeed, Yufei Chen, Emmanuel Ho, Ana Oliveira, Stephanie Martinez, Samaa Alrushaid, Neal Davies & Ted Lakowski. (2017) Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids. Pharmaceutics 9:4, pages 45.
Crossref
Crossref
Michael Horowitz, Vanita R. Aroda, Jenny Han, Elise Hardy & Chris K. Rayner. (2017) Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences. Diabetes, Obesity and Metabolism 19:5, pages 672-681.
Crossref
Crossref
Christopher K. Rayner, Karen L. Jones, Tongzhi Wu & Michael Horowitz. (2017) Gut feelings about diabetes and GLP-1 receptor agonists: lessons to be learnt from studies in functional gastrointestinal disorders. Diabetes, Obesity and Metabolism 19:3, pages 309-312.
Crossref
Crossref
Graciliana Lopes, Paula Andrade & Patrícia Valentão. (2016) Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2. Molecules 22:1, pages 56.
Crossref
Crossref
Yoshinori IbaKoji YokoiItsuka EitokuMasaki GotoSeiko KoizumiFumihito SugiharaHiroshi OyamaTadashi Yoshimoto. (2016) Oral Administration of Collagen Hydrolysates Improves Glucose Tolerance in Normal Mice Through GLP-1-Dependent and GLP-1-Independent Mechanisms. Journal of Medicinal Food 19:9, pages 836-843.
Crossref
Crossref
Kazuhiro Eto, Yusuke Naito & Yutaka Seino. (2015) Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trials. Diabetology & Metabolic Syndrome 7:1.
Crossref
Crossref
Barbara Sottero, Simona Gargiulo, Isabella Russo, Cristina Barale, Giuseppe Poli & Franco Cavalot. (2015) Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies. Medicinal Research Reviews 35:5, pages 968-1031.
Crossref
Crossref
Donna Ryan & Andres Acosta. (2015)
GLP
‐1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
. Obesity 23:6, pages 1119-1129.
Crossref
Crossref
Oscar Duems-Noriega & Sergio Ariño-Blasco. (2015) Subcutaneous fluid and drug delivery: safe, efficient and inexpensive. Reviews in Clinical Gerontology 25:2, pages 117-146.
Crossref
Crossref
Shigemasa Tani, Atsuhiko Takahashi, Ken Nagao & Atsushi Hirayama. (2015) Effect of Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin on Plasminogen Activator Inhibitor-1 in Patients With Diabetes Mellitus. The American Journal of Cardiology 115:4, pages 454-460.
Crossref
Crossref
Seungjoon OhSuk ChonKyu Jeong AhnIn-Kyung JeongByung-Joon KimJun Goo Kang. (2015) The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea. Diabetes & Metabolism Journal 39:3, pages 177.
Crossref
Crossref
Rosemarie Lajara, Richard Aguilar, Uwe Hehnke, Hans-Juergen Woerle & Maximilian von Eynatten. (2014) Efficacy and Safety of Linagliptin in Subjects With Long-standing Type 2 Diabetes Mellitus (>10 Years): Evidence From Pooled Data of Randomized, Double-blind, Placebo-controlled, Phase III Trials. Clinical Therapeutics 36:11, pages 1595-1605.
Crossref
Crossref
Qiang Du, Yan-Jun Wang, Sheng Yang, Yue-Yang Zhao & Ping Han. (2014) Liraglutide for the Treatment of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-Controlled Trials. Advances in Therapy 31:11, pages 1182-1195.
Crossref
Crossref
H. O. Koskela, P. H. Salonen, J. Romppanen & L. Niskanen. (2014) Long-term mortality after community-acquired pneumonia--impacts of diabetes and newly discovered hyperglycaemia: a prospective, observational cohort study. BMJ Open 4:8, pages e005715-e005715.
Crossref
Crossref